Investors Asset Management of Georgia Inc. GA ADV Sells 50 Shares of McKesson Co. (NYSE:MCK)

Investors Asset Management of Georgia Inc. GA ADV decreased its position in McKesson Co. (NYSE:MCK) by 1.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,579 shares of the company’s stock after selling 50 shares during the quarter. Investors Asset Management of Georgia Inc. GA ADV’s holdings in McKesson were worth $1,194,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Legacy Financial Group LLC bought a new stake in shares of McKesson in the 3rd quarter valued at approximately $27,000. OFI Invest Asset Management bought a new stake in McKesson during the third quarter worth approximately $26,000. BKM Wealth Management LLC bought a new stake in McKesson during the fourth quarter worth approximately $31,000. Live Oak Investment Partners bought a new stake in McKesson during the fourth quarter worth approximately $30,000. Finally, Covestor Ltd boosted its position in McKesson by 72.3% during the first quarter. Covestor Ltd now owns 81 shares of the company’s stock worth $25,000 after purchasing an additional 34 shares during the period. Institutional investors own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Argus upped their target price on McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. UBS Group upped their target price on McKesson from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 4th. Mizuho upped their price target on McKesson from $450.00 to $505.00 and gave the stock a “neutral” rating in a report on Friday, February 9th. Finally, SVB Leerink assumed coverage on McKesson in a report on Monday, February 26th. They set an “outperform” rating and a $600.00 price target for the company. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $533.50.

Insider Transactions at McKesson

In other news, EVP Leann B. Smith sold 186 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Leann B. Smith sold 186 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now owns 43,445 shares in the company, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

McKesson Stock Down 2.0 %

McKesson stock traded down $10.68 during mid-day trading on Thursday, hitting $515.24. 331,183 shares of the company were exchanged, compared to its average volume of 684,773. The business has a fifty day moving average of $523.95 and a 200 day moving average of $485.48. McKesson Co. has a 1-year low of $352.34 and a 1-year high of $543.00. The company has a market capitalization of $67.71 billion, a PE ratio of 23.83, a price-to-earnings-growth ratio of 1.43 and a beta of 0.45.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The firm had revenue of $80.90 billion during the quarter, compared to analyst estimates of $77.93 billion. During the same period in the prior year, the company posted $6.90 earnings per share. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year. Research analysts expect that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were issued a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a dividend yield of 0.48%. The ex-dividend date of this dividend was Thursday, February 29th. McKesson’s payout ratio is presently 11.24%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.